Arzeda, The Industry-Leading Protein Design Company, Closes $33 Million Series B Funding Led By Conti Ventures
Arzeda, The Industry-Leading Protein Design Company, Closes $33 Million Series B Funding Led By Conti Ventures
03/30/22, 10:00 AM
Location
seattleMoney raised
$33 million
Round Type
series b
Arzeda, the industry-leading Protein Design CompanyTM, announced today that it has closed a $33 million investment, in a Series B round of funding, led by Conti Ventures, the venture arm of investor Continental Grain Company. This round also includes investments from Lewis & Clark Agrifood, Bunge Ventures, the venture capital arm of the leading global agribusiness and food company Bunge, and Circulate Capital, among others, as well as repeat investments from Series A investors OS Fund, Casdin Capital, UMI and Bioeconomy Capital.
Company Info
Location
seattle, washington, united states
Additional Info
Arzeda harnesses the power of computation to create and manufacture proteins that enhance our lives and protect our planet. In partnership with Fortune 500 companies and industrial leaders, we develop healthy and sustainable products for the food & nutrition, advanced materials, and diagnostics & pharma industries globally. Arzeda's proprietary protein design platform combines physics-based computational protein design, machine learning, and lab automation to expand the reach of biotechnology beyond the solutions that nature evolved. For more information, please visit www.arzeda.com.